Abstract:We report here a series of coordinatively-saturated and thermodynamically stable luminescent [Ln(dtntp)(H2O)] [Ln(III) = Eu (1), Tb (2), Gd (3), Sm (4) and Dy (5)] complexes using an aminophenyl-terpyridine appended-DTPA (dtntp) chelating ligand as cell imaging and photocytotoxic agents. The N,N″-bisamide derivative of H5DTPA named as dtntp is based on 4'-(4-aminophenyl)-2,2':6',2″-terpyridine conjugated to diethylenetriamine-N,N',N″-pentaacetic acid. The structure, physicochemical properties, detailed photophysical aspects, interaction with DNA and serum proteins, and photocytotoxicity were studied. The intrinsic luminescence of Eu(III) and Tb(III) complexes due to f → f transitions used to evaluate their cellular uptake and distribution in cancer cells. The solid-state structure of [Eu(dtntp)(DMF)] (1·DMF) shows a discrete mononuclear molecule with nine-coordinated {EuN3O6} distorted tricapped-trigonal prism (TTP) coordination geometry around the Eu(III). The {EuN3O6} core results from three nitrogen atoms and three carboxylate oxygen atoms, and two carbonyl oxygen atoms of the amide groups of dtntp ligand. The ninth coordination site is occupied by an oxygen atom of DMF as a solvent from crystallization. The designed probes have two aromatic pendant phenyl-terpyridine (Ph-tpy) moieties as photo-sensitizing antennae to impart the desirable optical properties for cellular imaging and photocytotoxicity. The photostability, coordinative saturation, and energetically rightly poised triplet states of dtntp ligand allow the efficient energy transfer (ET) from Ph-tpy to the emissive excited states of the Eu(III)/Tb(III), makes them luminescent cellular imaging probes. The Ln(III) complexes show significant binding tendency to DNA (K ~ 104 M-1), and serum proteins (BSA and HSA) (K ~ 105 M-1). The luminescent Eu(III) (1) and Tb(III) (2) complexes were utilized for cellular internalization and cytotoxicity studies due to their optimal photophysical properties. The cellular uptake studies using fluorescence imaging displayed intracellular (cytosolic and nuclear) localization in cancer cells. The complexes 1 and 2 displayed significant photocytotoxicity in HeLa cells. These results offer a modular design strategy with further scope to utilize appended N,N,N-donor tpy moiety for developing light-responsive luminescent Ln(III) bioprobes for theranostic applications.

Pt(II)‐Phenanthroline‐Ln(III)‐DOTA d‐f Hybrids as Small‐Molecule Theranostics

Luminescent lanthanide(III) complexes of DTPA-bis(amido-phenyl-terpyridine) for bioimaging and phototherapeutic applications

Novel lanthanide–polymer complexes for dye-free dual modal probes for MRI and fluorescence imaging

Platinum(II)–Gadolinium(III) Complexes As Potential Single‐Molecular Theranostic Agents for Cancer Treatment

Ln(III) Chelates-Functionalized Carbon Quantum Dots: Synthesis, Optical Studies and Multimodal Bioimaging Applications.

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Organometallic d6, d8 and d10 metal complexes for biosensing and imaging, cancer therapy and theranosis

Correction To: Carbon Dots @ Platinum Porphyrin Composite As Theranostic Nanoagent for Efficient Photodynamic Cancer Therapy

Tetraphenylethene-Based Highly Emissive Metallacage As A Component of Theranostic Supramolecular Nanoparticles

Platinum(II)-Metallaclip-Based Theranostics for Cell Imaging and Synergetic Chemotherapy-Photodynamic Therapy

A first-in-class dual-chelator theranostic agent designed for use with imaging-therapy radiometal pairs of different elements

Radiochemistry and Complex Formation of the Cyclen-Derived Chelator DOTI-Me with Mn2+, Cu2+, Zn2+, Ga3+, In3+, Tb3+, and Lu3

Diphosphine Bioconjugates via Pt(0)-Catalyzed Hydrophosphination. A Versatile Chelator Platform for Technetium-99m and Rhenium-188 Radiolabeling of Biomolecules

Target-switchable Gd(III)-DOTA/protein cage nanoparticle conjugates with multiple targeting affibody molecules as target selective T1 contrast agents for high-field MRI

Recent Advances on Pt-Based Compounds for Theranostic Applications

Metal complexes as photochemical nitric oxide precursors : Potential applications in the treatment of tumors

Lanthanide porphyrinoids as molecular theranostics

A facile synthesis of a theranostic nanoparticle by oxidation of dopamine-DTPA-Gd conjugates

Rational design of an "all-in-one" phototheranostic

Biomedical applications of Pt(II) metallacycle/metallacage-based agents: From mono-chemotherapy to versatile imaging contrasts and theranostic platforms

Fluorescent Metallacycle‐Cored Amphiphilic Nanoparticles Formed by Β‐cyclodextrin‐based Host–Guest Interactions Towards Cancer Theranostics